Article Details

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI): Performance Review And Growth Outlook

Retrieved on: 2021-02-15 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI): Performance Review And Growth Outlook. View article details on hiswai:

Excerpt

Vanguard Group, Inc. (The) holds the second largest percentage of outstanding shares, with 3.36% or 1.2 Million shares worth $20.34 Million as of ...

Article found on: marketingsentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up